Verano Holdings (VRNO) Non-Current Deffered Revenue (2021 - 2023)
Verano Holdings (VRNO) posted quarterly Non-Current Deffered Revenue of $255000.0 for Q1 2023, little changed quarter-over-quarter from $255000.0 in Q4 2022.
Verano Holdings (VRNO) Non-Current Deffered Revenue (2021 - 2023) Analysis & Trends
Verano Holdings (VRNO) has reported Non-Current Deffered Revenue for 3 consecutive years, with $255000.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Non-Current Deffered Revenue changed N/A year-over-year to $255000.0; the TTM figure through Mar 2023 stood at $255000.0 (changed N/A YoY), while the FY2022 annual figure was $255000.0, down 78.44% from the prior year.
- Non-Current Deffered Revenue was little changed at $255000.0 in Q1 2023 per VRNO's latest filing, from $255000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $1.2 million in Q4 2021 and bottomed at $215000.0 in Q3 2022.
- Historically, Non-Current Deffered Revenue has averaged $435800.0 across 3 years, with a median of $255000.0 in 2022.
- On a YoY basis, Non-Current Deffered Revenue climbed as much as 78.44% in 2022 and fell as far as 78.44% in 2022.
- Verano Holdings' Non-Current Deffered Revenue stood at $1.2 million in 2021, then plunged by 78.44% to $255000.0 in 2022, then changed by 0.0% to $255000.0 in 2023.
- Business Quant data shows VRNO's Non-Current Deffered Revenue at $255000.0 in Q1 2023, $255000.0 in Q4 2022, and $215000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 271,000.00 |
| Dec 31, 2021 | 1.18 Mn |